Suppr超能文献

槲皮素在体内外对血管生成因子产生的抑制作用

Inhibition of Angiogenic Factor Productions by Quercetin In Vitro and In Vivo.

作者信息

Okumo Takayuki, Furuta Atsuko, Kimura Tarou, Yusa Kanako, Asano Kazuhito, Sunagawa Masataka

机构信息

Department of Physiology, Showa University School of Medicine, Tokyo 142-8555, Japan.

Department of Medical Education, Showa University School of Medicine, Tokyo 142-8555, Japan.

出版信息

Medicines (Basel). 2021 May 12;8(5):22. doi: 10.3390/medicines8050022.

Abstract

Angiogenesis is well known to be an important event in the tissue remodeling observed in allergic diseases. Although there is much evidence that quercetin, one of the most abundant dietary flavonoids, exerts anti-allergic effects in both human and experimental animal models of allergic diseases, the action of quercetin on angiogenesis has not been defined. Therefore, in this study, we first examined the action of quercetin on the secretion of angiogenic factors from murine mast cells in vitro. We also examined the action of quercetin on angiogenic factor secretion in the murine allergic rhinitis model in vivo. Mast cells (1 × 105 cells/mL) sensitized with ovalbumin (OVA)-specific murine IgE were stimulated with 10.0 ng/mL OVA in the presence or the absence of quercetin for 24 h. The concentrations of angiogenic factors, vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), tumor necrosis factor-α, IL-6 and IL-8 in the supernatants were examined by ELISA. BALB/c male mice immunized with OVA were challenged intranasally with OVA every other day, starting seven days after the final immunization. These mice were then orally administered quercetin once a day for five days, starting seven days after the final immunization. Clinical symptoms were assessed by counting the number of sneezes and nasal rubbing behaviors during the 10 min period just after OVA nasal provocation. The angiogenic factor concentrations in the nasal lavage fluids obtained 6 h after nasal antigenic provocation were examined by ELISA. Quercetin significantly inhibited the production of angiogenetic factors induced by IgE-dependent mechanisms at 5.0 µM or more. Oral administration of 25.0 mg/kg quercetin into the mice also suppressed the appearance of angiogenetic factors in nasal lavage fluids, along with the attenuation of nasal symptoms. These results strongly suggest that the inhibitory action of quercetin on angiogenic factor secretion may be implicated in the therapeutic action of quercetin on allergic diseases, especially allergic rhinitis.

摘要

众所周知,血管生成是过敏性疾病中组织重塑的一个重要事件。尽管有大量证据表明,槲皮素作为饮食中最丰富的类黄酮之一,在人类和过敏性疾病实验动物模型中均具有抗过敏作用,但槲皮素对血管生成的作用尚未明确。因此,在本研究中,我们首先在体外检测了槲皮素对小鼠肥大细胞血管生成因子分泌的作用。我们还在体内小鼠过敏性鼻炎模型中检测了槲皮素对血管生成因子分泌的作用。用卵清蛋白(OVA)特异性小鼠IgE致敏的肥大细胞(1×105细胞/mL)在存在或不存在槲皮素的情况下,用10.0 ng/mL OVA刺激24小时。通过酶联免疫吸附测定法检测上清液中血管生成因子、血管内皮生长因子(VEGF)、碱性成纤维细胞生长因子(bFGF)、肿瘤坏死因子-α、白细胞介素-6和白细胞介素-8的浓度。用OVA免疫的BALB/c雄性小鼠在最后一次免疫后7天开始,每隔一天经鼻给予OVA。然后,这些小鼠在最后一次免疫后7天开始,每天口服一次槲皮素,持续5天。通过计算OVA鼻激发后10分钟内的喷嚏次数和鼻摩擦行为来评估临床症状。通过酶联免疫吸附测定法检测鼻抗原激发6小时后获得的鼻灌洗液中血管生成因子的浓度。槲皮素在5.0 µM或更高浓度时显著抑制IgE依赖机制诱导的血管生成因子的产生。给小鼠口服25.0 mg/kg槲皮素也可抑制鼻灌洗液中血管生成因子的出现,并减轻鼻部症状。这些结果有力地表明,槲皮素对血管生成因子分泌的抑制作用可能与槲皮素对过敏性疾病,尤其是过敏性鼻炎的治疗作用有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17f2/8150841/0423c556025a/medicines-08-00022-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验